These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34689593)

  • 1. Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling.
    Liu G; Wan N; Liu Q; Chen Y; Cui H; Wang Y; Ren J; Shen X; Lu W; Yu Y; Shen Y; Wang J
    Hypertension; 2021 Dec; 78(6):1914-1926. PubMed ID: 34689593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitor LF3 restrains the development of pulmonary hypertension through the Wnt/β-catenin pathway.
    Lei Y; Yang Q; Nie Y; Wan J; Deng M
    Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1277-1289. PubMed ID: 34410330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension.
    Takahashi J; Orcholski M; Yuan K; de Jesus Perez V
    FEBS Lett; 2016 Jan; 590(1):101-9. PubMed ID: 26787464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid.
    Saito Y; Nakamura K; Miura D; Yunoki K; Miyoshi T; Yoshida M; Kawakita N; Kimura T; Kondo M; Sarashina T; Akagi S; Watanabe A; Nishii N; Morita H; Ito H
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28796175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
    Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K
    J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats.
    Tang M; Wang R; Feng P; Dong Q; Chen W; Zhao Y; Li A; Li H; Chen J; Huang W
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):337-348. PubMed ID: 32569012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification.
    Carracedo M; Artiach G; Witasp A; Clària J; Carlström M; Laguna-Fernandez A; Stenvinkel P; Bäck M
    Cardiovasc Res; 2019 Aug; 115(10):1557-1566. PubMed ID: 30597013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine alleviates pulmonary hypertension through Trx1 and β-catenin signaling pathways in pulmonary artery smooth muscle cells.
    Wande Y; Jie L; Aikai Z; Yaguo Z; Linlin Z; Yue G; Hang Z
    Exp Cell Res; 2020 May; 390(1):111910. PubMed ID: 32147507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.
    Cheng SL; Shao JS; Halstead LR; Distelhorst K; Sierra O; Towler DA
    Circ Res; 2010 Jul; 107(2):271-82. PubMed ID: 20489161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt5a inhibits hypoxia-induced pulmonary arterial smooth muscle cell proliferation by downregulation of β-catenin.
    Yu XM; Wang L; Li JF; Liu J; Li J; Wang W; Wang J; Wang C
    Am J Physiol Lung Cell Mol Physiol; 2013 Jan; 304(2):L103-11. PubMed ID: 23144322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
    Liu YY; Zhang WY; Wang CG; Huang JA; Jiang JH; Zeng DX
    Microvasc Res; 2020 Jul; 130():103988. PubMed ID: 32057731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells.
    Qian Z; Li Y; Yang H; Chen J; Li X; Gou D
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L965-L976. PubMed ID: 30211651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
    Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J
    Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries.
    Hiram R; Rizcallah E; Marouan S; Sirois C; Sirois M; Morin C; Fortin S; Rousseau E
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L776-88. PubMed ID: 26320154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.